Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Reg Anesth Pain Med ; 48(8): 425-427, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-36792313

RESUMO

BACKGROUND: Medications for opioid use disorder (MOUD) are a life-saving intervention; thus, it is important to address barriers to successful initiation. Spasticity affects many patients with spinal cord injury and can be painful and physically debilitating. Chronic painful conditions can lead to the illicit use of non-prescribed opioids, but fear of pain is a barrier to the initiation of MOUD. In this case report, we describe the novel use of botulinum toxin A injections to treat abdominal spasticity and facilitate Acute Pain Service-led buprenorphine/naloxone initiation in a patient with opioid use disorder and severe abdominal spasticity due to spinal cord injury. CASE PRESENTATION: A patient with C4 incomplete tetraplegia and opioid use disorder complicated by abdominal spasticity refractory to oral antispasmodics and self-treating with intravenous heroin was referred to the Acute Pain Service for inpatient buprenorphine/naloxone initiation. The patient began to fail initiation of buprenorphine/naloxone secondary to increased pain from abdominal spasms. The patient was offered ultrasound-guided abdominal muscle chemodenervation with botulinum toxin A, which resulted in the resolution of abdominal spasticity and facilitated successful buprenorphine/naloxone initiation. At 6 months post-initiation, the patient remained abstinent from non-prescribed opioids and compliant with buprenorphine/naloxone 8 mg/2 mg three times a day. CONCLUSIONS: This case report demonstrates that inpatient buprenorphine/naloxone initiation by an Acute Pain Service can improve the success of treatment by addressing barriers to initiation. Acute Pain Service clinicians possess unique skills and knowledge, including ultrasound-guided interventions, that enable them to provide innovative and personalized approaches to care in the complex opioid use disorder population.


Assuntos
Anestesia por Condução , Toxinas Botulínicas Tipo A , Buprenorfina , Transtornos Relacionados ao Uso de Opioides , Humanos , Analgésicos Opioides/efeitos adversos , Antagonistas de Entorpecentes , Clínicas de Dor , Toxinas Botulínicas Tipo A/uso terapêutico , Combinação Buprenorfina e Naloxona/uso terapêutico , Naloxona/uso terapêutico , Transtornos Relacionados ao Uso de Opioides/diagnóstico , Dor/tratamento farmacológico
2.
A A Pract ; 16(8): e01614, 2022 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-35960934

RESUMO

Rib fractures carry high morbidity and mortality due to pain-related complications, such as hypoventilation, atelectasis, and pneumonia. Ultrasound-guided regional anesthesia is a common treatment for pain associated with rib fractures. But, due to a variety of reasons, ultrasound images can be ambiguous or unhelpful. In these instances, it is advantageous to have a tactile or landmark-based approach to treating rib fracture pain. We present a case of a continuous retrolaminar nerve block catheter placed without ultrasound guidance in a 67-year-old man with oxygen-dependent chronic obstructive pulmonary disease and a prior intrathecal pump, who presents with multiple unilateral rib fractures.


Assuntos
Bloqueio Nervoso , Fraturas das Costelas , Fraturas da Coluna Vertebral , Idoso , Catéteres/efeitos adversos , Humanos , Masculino , Bloqueio Nervoso/métodos , Dor/etiologia , Manejo da Dor/métodos , Fraturas das Costelas/terapia
3.
Reg Anesth Pain Med ; 47(4): 275-276, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-34815365
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA